← Leaderboards
Sandra Burchett
Children'S Hospital Boston
$2,668
Attributed
$2,668
Total exposure
4
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$2,668 · 4
By mechanism
M01$2,668 · 4
Top collaborators
No co-investigators on record.
Most similar at Children'S Hospital Boston
Same institution · by research overlap
- Kenneth J McIntosh$8,678,025
- Gabriel Corfas$17,686,016
- David C Bellinger$6,830,078
- Ekaterina Heldwein$16,788,591
- Marian R. Neutra$2,788,285
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHiv InfectionsHuman Therapy EvaluationAids TherapyChild (0-11)Women'S HealthPerinatalClinical Trial Phase IHuman MilkHuman SubjectPediatric AidsAntiaids AgentVertical TransmissionFemaleDrug Screening /EvaluationData CollectionCytomegalovirusCongenital InfectionHuman Immunodeficiency Virus 1Human DataComputer Assisted Patient CareHuman Pregnant SubjectChickenpoxHerpesviridae Disease
Grant awards (4)
ACTG 265--SAFETY AND IMMUNOGENICITY OF LIVE ATTENUATED VARICELLA VACCINE$667
M01 · FY2000 · RR
CYTOMEGALOVIRUS INFECTION IN PRETERM INFANTS$667
M01 · FY2000 · RR
RAD 1: PHASE I &II ANTIRETROVIRAL MANAGEMENT ALGORITHM FOR PEDIATRIC SUBJECTS$667
M01 · FY2000 · RR
PHASE III RANDOMIZED BLINDED STUDY OF NEVIRAPINE VS NEVIRAPINE PLACEBO$667
M01 · FY2000 · RR